NERVGEN PHARMA CORP

NGENNASDAQ

Earnings Nov 12US Equity

$1.50▼ $0.00 (−0.33%)

Latest quote

Get earnings, price moves & breaking news on Telegram

24h▼ 0.3%

7d▲ 5.3%

14d▼ 7.1%

30d▼ 22.3%

ytd—

1y—

🏦Market Cap

$161M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

—

Insufficient data

Earnings

Q3 · 2026Reported 2026-08-13

Earnings Per Share

Actual

-0.37

Expected

-0.06

miss

−510.80%

YoY −293.70%

Revenue

Actual

—

Expected

$4.50K

—

—

Consensus estimates

Recent quarters

Q3 2026

-0.37

miss

Q2 2026

-0.01

beat

Q2 2026

-0.26

miss

Q4 2025

-0.04

beat